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Staphylococcus aureus is an important human pathogen that causes wide arrays of 
infections ranging from minor skin infections to lethal systemic conditions such as 
infective endocarditis, osteomyelitis, sepsis and pneumonia. These systemic diseases are 
often difficult to treat due to the presence of persister cells. Persister cells are a 
phenotypic variant of the bacterial population that exhibit extreme and transient antibiotic 
tolerance accompanied by a transient halt in growth. Upon cessation of antibiotic 
treatment, however, persisters resume growth which results in recurrence of infections. 
This characteristic of persister cells therefore displays high clinical significance. In this 
study, we show the involvement of the msaABCR operon in antibiotic tolerance in S. 
aureus under the clinically relevant bactericidal antibiotic gentamicin. In previous study, 
the msaABCR operon was found to involve in persister cells formation such that the 
deletion of the msaABCR operon showed decreased persister formation in the methicillin 
resistant S. aureus (MRSA) strain USA300 LAC (Sahukhal et al. 2017). The RNA 
transcriptome of the msaABCR deletion mutant showed differential expression of genes 
that are involved in various metabolic pathways including carbohydrate, amino acid 
pathways (Sahukhal et al 2017). Considering the importance of metabolism in antibiotic 
tolerance, first we examined the expression of tricarboxylic acid (TCA) genes to measure 
the TCA cycle activity. The qRT-PCR results showed that the msaABCR deletion mutant 
indeed has increased expression of TCA genes and higher ATP content (Sahukhal et al., 
2017). Furthermore, we evaluated the antibiotic tolerance in TCA cycle mutants in S. 
aureus. The results showed that the transposon mutants of TCA cycle genes exhibit 
higher antibiotic tolerance as compared to the wild type USA300 LAC. Considering the 
 
iv 
importance of energy content in the antibiotic tolerance, we also measured the ATP 
content and membrane potential. Deletion of TCA genes leads to decreased cellular ATP 
content as well as reduced membrane potential. We also observed increased pigment 
production and biofilm production in the TCA mutants. Altogether, these results suggest 
that the reduced metabolic activity contributes to the antibiotic tolerance as well as 
virulence in S. aureus. 
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CHAPTER I – INTRODUCTION 
1.1 Staphylococcus aureus 
S. aureus is a gram-positive coccus, non-motile and non-spore forming bacterial 
pathogen that belongs to the Firmicutes phylum and Bacilli class. This bacterium is 
facultative anaerobe measuring 0.7-1.2 μm in diameter. S. aureus is the most common 
pathogen among Staphylococcus genus that causes wide arrays of infections in human. 
In 1882, Ogston examined pus from a surgical abscess and named these bacteria 
“staphylococci”, derived from the Greek words staphyle, referring to “the bunch of 
grape”, and kokkos denoting “berry”, referring to the bacterial structures as observed 
under microscope (Ogston, 1882). In 1884, Rosenbach noted white and pigmented 
staphylococci. The species that showed the golden pigmented colonies was then named S. 
aureus, derived from the Latin word aurum meaning “gold” (Licitra, 2013). In 1903, 
Loeb observed coagulation of blood by S. aureus (Loeb, 1903), which is widely known 
as the coagulase test (clotting of blood plasma) to differentiate S. aureus from other 
coagulase negative staphylococci (CNS) (Loeb, 1903). Likewise, S. aureus produces a 
catalase enzyme, and this property is tested to differentiate the pathogen from 
streptococci. 
S.aureus is an important human pathogen that can cause wide arrays of infection 
ranging from the minor skin infections to often lethal systematic infections such as 
osteomyelitis, sepsis, infective endocarditis and pneumonia (Lowy, 1998). S. aureus are 
also commensal bacteria found amongst 30% of the human population (Gorwitz et al., 
2008; Kluytmans et al., 1997). However, underlying immunocompromised conditions or 




1.1.1 S. aureus is a Health Burden Worldwide 
S. aureus is a major bacterial pathogen that can cause a remarkably diverse array 
of infections ranging from acute skin infections to systemic and often life-threatening 
conditions such as endocarditis, bacteremia, osteomyelitis and pneumonia (Lowy, 1998). 
S. aureus is the prime causative agent of bacteremia and infective endocarditis (Tong et 
al., 2015). In addition to this, the bacteria are also a major source of osteoarticular 
infections, pleuropulmonary infections, skin and soft tissue infections, and surgical 
device related infections (Tong et al., 2015). Despite the clinical relevance, there is an 
absence of an effective vaccine against S. aureus.  
The ability of S. aureus to cause a variety of infections is mainly due to various 
virulence factors, antibiotic resistance, and their ability to escape the host immunity 
(Foster, 2009; Johnson, 2011; Lowy, 1998). Immunocompromised individuals with 
underlying conditions such as diabetes, vascular diseases, cancer or the patients 
prescribed with hospital devices such as tips or catheters have a higher risk of getting S. 
aureus infections (https://www.cdc.gov/hai/organisms/staph.html). S. aureus was further 
reported to be the major cause of healthcare associated (HA) infections. In addition, 
within the past decade, community acquired (CA) S. aureus infections have been 
consistently increasing. In 2004, the methicillin resistant S. aureus (MRSA) strain 
USA300 was reported to be the most common cause (more than 98%) of the emergency 
cases in soft tissue infections in 11 cities in the US (Moran et al., 2006). In 2017, Centers 
for Disease Control and Prevention (CDC) reported >119,000 MRSA associated 
bacteremia cases with ~20,000 deaths in the U. S. alone (Kourtis AP, 2019). 
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Additionally, MRSA is also reported to be the leading cause of infective 
endocarditis, accounting for ~50,000 incidences per year. The annual treatment cost for 
MRSA infections was reported to range between 4 to 30 billion dollars in the US alone 
(Moran et al., 2006). Due to its ability to cause severe diseases, S. aureus infections result 
in high morbidity and mortality rates, thus imposing a high socio-economic burden 
worldwide (Kourtis et al., 2019). In addition to North America, CA-MRSA has also been 
reported in Asia, Europe, South America, and Australia (Chambers & Deleo, 2009).  
1.2 Persister Cells  
Persister cells are a phenotypic variant of the bacterial population that are 
extremely tolerant to antibiotics. This tolerance property is transient and is accompanied 
by a transient halt in growth. Persister cells are characterized as dormant, non- growing 
cells (Brian P. Conlon, 2014). When a bacterial culture is exposed to a lethal 
concentration of bactericidal antibiotic, a bulk of the population is killed. However, a 
small fraction of cells are left intact form a characteristic persister plateau. This antibiotic 
tolerance property gives rise to a characteristic biphasic killing curve during in vitro 
experiments (Kim Lewis, 2010). Once antibiotic treatment is discontinued, the dormant 
persister cells are capable of resuming growth and producing a cell population identical 
to that of the original (Shah et al., 2006). The population produced by the persister cells 
has also been found to have a similar fraction of antibiotic tolerant vs non tolerant cells to 
that of the original population (Iris Keren et al., 2004). 
Persister cells behave in a manner that allows them to avoid antibiotic killing 
without genetic modification (Balaban et al., 2004). Antibiotics commonly used on S. 
aureus infections were manufactured to target the mechanisms and processes that are 
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active during cellular growth (Fauvart et al., 2011). Since persister cells undergo 
dormancy, antibiotics therefore become ineffective against this specific population 
(Fauvart et al., 2011).  
Because persister cells contain the ability to tolerate antibiotic exposure for 
extended periods of time and regrow upon the removal of antibiotic treatment, persister 
cells are thought to be one of the major causes of reoccurring S. aureus infections (I. 
Keren et al., 2004; Wood et al., 2013). The mechanism concerning persister cell 
formation is not directly understood, but there is evidence that factors such as reduced 
ATP concentrations contribute to the antibiotic tolerance (Brian P. Conlon et al., 2016). 
1.2.1 Mechanisms Underlying Persister Formation is Poorly Understood 
Although the persister phenomenon was discovered more than 70 years ago, the 
mechanisms of persister formation in S. aureus are not well understood. Previously, 
stringent response or dormancy were regarded as the contributing factors for bacterial 
persistence. However, recent studies have challenged these findings such that the deletion 
of toxin-antitoxin systems did not decrease persister formation (Dawson et al., 2011; 
Harms et al., 2017; Svenningsen et al., 2019; Wood et al., 2013); making a persister 
switch even more of an elusive bacterial phenomenon. Therefore, understanding the 
mechanisms of persister formation has been extremely challenging, mainly due to their 
transient nature and small population size.  
1.2.2 Reduced Metabolism Increases Persister Cells Formation  
Recently, an increasing number of studies have examined the contribution of 
metabolic genes in the formation of S. aureus persister cells. For example, Yee et al. 
reported the contribution of purine genes in persister cell formation (Yee et al., 2015). 
 
13 
Wang et al. showed that inactivation of succinate dehydrogenase (sdhA/B) forms a lower 
population of persister cells against different stressors, including antibiotics (Wang et al., 
2015). Likewise, the mutant of phoU showed decreased persisters due to increased 
metabolic activity (Shang et al., 2020). Recent studies have found that the environmental 
conditions that have normally been correlated with interrupting transcription, translation 
or the synthesis of ATP actually increase persister fraction  (B. P. Conlon et al., 2016; 
Shan et al., 2017; Wood et al., 2013). Studies have shown that the inactivation of TCA 
cycle genes drastically increases persister cells ((Wang et al., 2018; Zalis et al., 2019). A 
decrease in ATP levels has resulted in a higher persister cell frequency during the 
exponential growth phase (B. P. Conlon et al., 2016; Zalis et al., 2019), while also noting 
that persister cell frequency is characterized by lower membrane potentials during the 
stationary phase or in a polymicrobial culture (Nabb et al., 2019; Wang et al., 2018). The 
reduced ATP level as the cause for increased persister fraction was also observed in the 
mutant of carbamoyl phosphate synthetase (carB) in the major pathogens S. aureus, E. 
coli, and P. aeruginosa (Cameron et al., 2018). These findings highlight the importance 
of metabolism in persister formation such that the inactivation of TCA enzymes result in 
a drastic increase in persister frequency.  
1.3 Staphylococcal Virulence Factors 
Virulence factors are defined as the molecules that increase the potential of a 
pathogen to cause disease (Heilmann, 2011). Virulence factors have been known to 
transfer from one strain to another through a process called horizontal gene transfer 
(Morikawa et al., 2012). S. aureus possess a plethora of virulence factors including but 
not limited to: the production of biofilms, capsules, pigments and proteases. Each of these 
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virulence factors help S. aureus to cause various diseases by aiding in averting the host 
defense systems (Otto, 2014). 
1.3.1 Role of Biofilms in Antibiotic Tolerance 
S. aureus biofilms are composed of a matrix of bacteria derived from extracellular 
polysaccharides, proteins, DNA and host-derived fibrin matrices. These structures 
provide environmental niches such as low nutrient level and gradient of pH (Kavanaugh 
& Horswill, 2016). Such unfavorable conditions provide a selection pressure for the 
generation of antibiotic insensitive persister cells, which are metabolically inactive with 
the presence of reduced ATP content (Lewis, 2008; Waters et al., 2016). Since the 
biofilms disperse, these infections can also result in metastatic infections (Lewis, 2001; 
K. Lewis, 2007).   
Considering the importance of biofilms in treatment failures, several approaches 
have been proposed to effectively kill persisters within S. aureus biofilms. For example, 
Study by Allison et al. in a mouse catheter model showed the eradication of the persisters 
by potentiating the aminoglycosides drugs with the addition of metabolites such as 
fructose and mannitol. These metabolites were shown to enhance the gentamicin uptake 
via generation of proton motive force (PMF) resulting into eradication of S. aureus and E. 
coli biofilms (Allison et al., 2011). Likewise, L-arginine via pH mediated mechanism was 
also shown to facilitate biofilm eradication by gentamicin in catheter-based biofilms 
formed in mice (Lebeaux et al., 2014). Another approach used an energy independent 
synthetic acyldepsipeptide antibiotic ADEP4 that could degrade more than 400 proteins. 
In combination with rifampicin, ADEP4 was shown to eradicate catheter model infection 
in mice (Conlon et al., 2013). The undeniable link between the recalcitrance of chronic 
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infections and persister formation is what sparked further research into the topic of 
persister cells, as well as the urgency to understand the mechanisms behind their 
formation (Lafleur et al., 2006; Kim Lewis, 2007).  
1.4 Role of the msaABCR Operon in Persister Cells Formation 
The msaABCR operon comprises four genes (msaA, msaB, msaC and anti-sense 
msaR) were identified and characterized by the Elasri research group (Sahukhal & Elasri, 
2014). Among these four genes, msaB encoding MsaB (also known as CspA) is the only 
protein coding gene. However, msaC, is a non-protein coding RNA that is essential to 
regulate the function of the msaABCR operon. The anti-sense msaR that is 
complementary to the 5’end of the msaB expresses differentially based on the growth 
phase of S. aureus (Sahukhal & Elasri, 2014). Previous studies conducted in Elasri lab 
have demonstrated the role of the msaABCR operon in biofilm development (Sahukhal et 
al., 2015; Sahukhal & Elasri, 2014), capsule production (Batte et al., 2018), and antibiotic 
resistance and tolerance in S. aureus. The deletion of the msaABCR operon was found to 
form decreased persister cells in both planktonic and biofilm growth conditions as 
compared to the wild type USA300 LAC in the presence of several clinically relevant 
antibiotics (Sahukhal et al., 2017).  
In this study, we examine the role of msaABCR in TCA cycle activity. 
Furthermore, using the TCA mutants, we also show the importance of metabolism in 
virulence of S. aureus. Altogether, this study suggests that the msaABCR operon plays 
role in the adaptation of S. arureus in different environmental stressors as well as via 




 CHAPTER II-MATERIALS AND METHODS 
2.1 Growth Conditions and Bacterial Strains 
The bacterial strains used for the study were methicillin-resistant Staphylococcus 
aureus (MRSA) USA 300 LAC, isogenic msaABCR operon mutant (msaABCR) and the 
complement of the operon strain (complementation). First of all, the cultures of S. aureus 
cells were prepared by inoculating cells from frozen culture. The cells from the frozen 
culture were placed into 5 ml fresh tryptic soy broth (TSB; Becton, Dickinson and 
Company, MD, USA) and incubated at 37 C with continuous shaking at a 225 rpm. 
After 2-3 h of incubation, cells were normalized to OD600 nm of 0.05 in 5 ml TSB and 
incubated further for 16 h to prepare the stationary phase culture. Bacterial strains used in 
this study are listed in Table 3.2. 
The production of the msaABCR operon deletion in USA300 LAC achieved 
through the allelic replacement method as previously described (Batte et al., 2016; 
Sahukhal & Elasri, 2014). The ORF of the msaABCR operon region was then cloned into 
the pCN34 low-copy-number vector for trans-complementation. For this process, the 
kanamycin selectable marker was changed to a chloramphenicol resistance marker.  
2.2 Generation of Transposon Mutants  
 The plasmid-cured derivatives of the LAC strain JE2 carrying transposon 
mutations in the specific coding regions of the desired genes were acquired from the 
Network of Antimicrobial Resistance in the S. aureus (NARSA) collection. The 
mutations were transferred to USA300 LAC strain or UAMS-1 strain through the 
generalized transduction process. The bacteriophage φ11 was utilized in this process. 
Through amplification of the beginning and end of the open reading frame (ORF) for the 
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designated genes, the transduction of the mutation into the desired strains was confirmed 
by end-to-end PCR as described previously (Batte et al., 2016; Pandey et al., 2019). 
2.3 Persister Assay  
The pre-cultures prepared as mentioned above were normalized to OD600 nm 
value of 0.05 in 5 ml of TSB at a flask-to-medium ratio of 10:1. After normalization, the 
cultures were then incubated at 37 C until stationary growth phase (16 h). The cultures 
were standardized in 3 ml of TSB. For the measurements of initial colony forming units 
(CFUs) count, 100 μl of the standardized culture was withdrawn before adding 
antibiotics, and serial diluted in 900 μl of 1 × phosphate buffer saline (PBS) and plated 
on the tryptic soy agar (TSA) plates. The rest of the cultures were then exposed to 
gentamicin (20 μg/ml, 20 × MIC). Then the cultures were incubated at 37 C with 
continuous shaking. At the designated time after exposure to the antibiotic, 100 μl of each 
sample was removed and washed with 900 μl of 1× PBS. These samples were then plated 
and incubated for 24 h to obtain final CFUs count.  
 Stationary phase cells were exposed to 10 μM carbonyl cyanide m-chlorophenyl 
hydrazone (CCCP) or different concentration of fumarate (15 mM, 30mM and 50 mM) 
for a thirty minute before exposure to gentamicin. At 24 h post exposure, 100 μl of cells 
were collected, washed, and plated to obtain a value for the CFUs.  
2.4 Measurement of pH and acetate 
Cells grown until stationary phase in 5 ml TSB as mentioned above were 
centrifuged and the supernatant was transferred to new tube. Then pH in the supernatant 
was measured by Accumet with Fisher brand pH meter. Similarly, cells grown to 
stationary phase were centrifuged and the supernatant was preserved in -80°C to measure 
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the acetate accumulation. The acetate was measured in the preserved culture supernatant 
according to the manufacturer instruction (R-biopharm, Washington, MO). 
2.5 RNA Extraction, Reverse Transcription, and qRT-PCR 
From the appropriate growth cultures, 500 μl amounts were treated with 
RNAprotect bacterial agent (Qiagen, Valencia, CA) for 5 minutes at room temperature. 
Extracting of the total RNA was done through the use of the Qiagen RNeasy kit (Qiagen), 
and the extracted RNA was analyzed with the NanoDrop spectrophotometer (Thermo-
Scientific) in order to observe the quality and concentration of the extracted RNA. The 
iScript cDNA synthesis kit (Bio-Rad Laboratories, Hercules, CA) was used for reverse 
transcription. This process was done by using 1 μg of the total RNA according to the 
instructions provided by the manufacturer. SYBR Green supermix (Bio-Rad) was used to 
do qRT-PCR. The relative fold change for gene expression was then calculated through 
the use of gyrB as an endogenous control gene. The primers used in this study are listed 
in table 3.2. 
2.6 Measurement of ATP 
The BacTiter-Glo kit (Promega, WI, USA) was used to measure the value for 
intracellular ATP content. At the designated phase, the cells were adjusted to an OD600 
nm of 0.025 in 1 ml of TSB. From there, 50 μl aliquots were transferred into the wells of 
an opaque 96-well plate and mixed with the BacTiter-Glo Reagent. The resultant 






2.7 Measurement of Membrane Potential 
The BacLight Bacterial Membrane Potential kit (Life Technologies, USA) was 
used to examine membrane potential. The cells when reached stationary phase were 
washed and normalized to OD600nm of 1.0 in 0.5 ml of filtered PBS. After resuspension, 
16.6 μl of fluorescent membrane potential indicator dye 3,3’- diethyloxacarbocyanine 
iodide (DIOC2(3)) were added and then incubated for 30 minutes at room temperature. 
The fluorescent signals were recorded for 100,000 cells through the use of a LSRFortessa 
flow cytometer (BD Biosciences, CA, USA). The negative control cells were incubated 
in 10 μm CCCP for 30 minutes before adding (DIOC2(3)). The ratio for red fluorescence 
(PE-A) to green fluorescence (FITC) was calculated and analyzed through the use of 
FlowJo v10 software. 
2.8 Statistical Analysis 
 The GraphPad Prism software was used to analyze the data. Specifically, the 
student’s t-test (unpaired) or one-way analysis of variance (ANOVA) accompanied by 
Tukey’s multiple comparison test with a p value of less than 0.05 being considered as 






3.1 Measurement of growth kinetics and minimum inhibitory concentration (MIC) 
values 
Before conducting persister assays, we measured the growth kinetics of the 
mutant of TCA genes citrate synthase (encoded by gltA), succinate dehyderogenase 
(sucA) and fumarate hydratase (fumC) in the nutrient rich medium TSB. To represent the 
early, middle and late genes in the TCA cycle, these genes were chosen in this study. The 
results show that although the exponential growth was similar to the wild type USA300 
LAC, the gltA and fumC mutant showed reduced growth rate as compared to the wild 
type USA300 LAC measured in the stationary phase (Fig. 3.1). Considering the clinical 
relevance of antibiotic tolerance, in this study we measured the persister frequency in the 
presence of aminoglycoside drug gentamicin. To determine the MIC values, standard 
micro-broth dilution method was followed. Deletion of the msaABCR operon as well as 
the TCA genes gltA, sucA and fumC did not change the susceptibility of S. aureus 
towards gentamicin (Table 3.1).  
Table 3.1 Minimum Inhibitory Concentration (MIC) value of gentamicin 
Strains 
Minimum Inhibitory Concentration of gentamicin 
(μg/ml) 









Considering the importance of growth of bacterial cells in persister formation, we 
also examined the growth kinetics of all the strains in the nutrient rich medium TSB in 
the absence of antibiotics. The results show that the inactivation of gltA and fumC 
reduced the growth rate in USA300 LAC while sucA showed similar growth kinetics as  
comparable to the wild type (Fig. 3.1).  
 
Figure 3.1 Measurement of growth kinetics 
Growth rate measurement in nutrient rich TSB medium until the stationary-phase of growth (48 h). The 
normalized cultures were incubated at 37° C and the absorbance of the culture was taken at OD600 nm 
each hour. Data represents the OD600 nm readings at the designated time points. Error bars represent 
standard error (SE) of the mean of the three replicates.  
3.2 The msaABCR mutant has higher TCA cycle activity and the cellular ATP level  
Previous study showed the involvement of the msaABCR operon in persister cells 
























hypothesized that the deletion of the msaABCR operon in S. aureus cells results in 
increased metabolic activity resulting in decreased persisters in the msaABCR mutant. To 
test this, we measured the TCA cycle activity by measuring the expression of the TCA 
genes. Since, the TCA cycle is activated during the late exponential phase to generate 
ATP when glucose is depleted; we measured the expression of TCA genes citrate 
synthase (gltA), aconitate hydratase (acnA), isocitrate dehydrogenase (icd), 2- 
oxoglutarate (sucA), succinyl-CoA synthetase (sucD), succinate dehydrogenase (sdhA/B), 
and fumarate hydratase (fumC) during this growth phase. The qRT-PCR results show 
increased expression of these genes in the msaABCR mutant compared to the wild type 
USA300 LAC (Figure 3.2A). Furthermore, we also measured the ATP and found that the 
msaABCR mutant contains higher ATP levels relative to the USA300 LAC strain in the 
late exponential growth (Figure 3.2B).  
 
Figure 3.2 Measurement of TCA cycle activity and intracellular ATP level 
Fold change expression of TCA genes (gltA, acnA, icd, sucA, sucD, sdhA/B, and fumC) in late exponential 
growth phase for the msaABCR mutant compared with the USA300 LAC strain, as measured by qRT-PCR. 
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(B) The ATP concentrations per CFU of all strains in late exponential phase. The data represent the average 
of three measurements with two biological replicates. Error bars represent the standard error of the mean 
(SEM) for three independent experiments. Statistical significance was determined using analysis of 
variance (ANOVA) followed by Tukey’s multiple comparison test. *, P ≤0.05; ns, not significant. 
3.3 Inactivation of TCA genes increases persister formation 
Since, we observed increased expression of TCA genes in the msaABCR mutant, 
we sought to examine the role of the TCA genes in antibiotic tolerance. For this, we 
performed the persister assay in mutants of the TCA cycle genes gltA, sucA and fumC in 
USA300 LAC background in the presence of gentamicin. Consistent with the previous 
studies, the results showed that the inactivation of TCA genes drastically increases the 
persister formation in USA300 LAC (Fig. 3.3).  
 
 
Figure 3.3. Persister assay in TCA mutants in the stationary phase of growth.  
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Cells grown to stationary phase (16 h) were standardized and were exposed to antibiotic gentamicin (20 × 
MIC). At 24 h post exposure, cells were harvested, washed in PBS and serially diluted and plated for the 
persister count. The data represent the fraction of surviving cells as compared to the initial count (before 
adding antibiotic). Error bars represent the mean of the standard error (SEM) of at least three replicates.   
These results show the importance of metabolic genes in the persister formation 
such that the inactivation of TCA genes lead to increased persister formation.  
3.4 Addition of fumarate increases persister formation 
Previous studies have shown variation in persister formation in E. coli and P. 
aeruginosa by intracellular fumarate concentration (Kim et al., 2016; Meylan et al., 
2017). To test whether fumarate increases the persister formation in S. aureus cells, we 
measured the persister frequency in presence of exogenously added fumarate. Our results 
show that addition of fumarate increased the persister frequency in dose dependent 
manner both in wild type and msaABCR mutant (Fig. 3.4).  
 
 
Figure 3.4 Exogenously added fumarate increases the persister frequency  
 
27 
Cells grown to the late exponential phase were divided into two tubes (3 ml each) and exposed to 
gentamycin and gentamycin with fumarate. The persister frequency was estimated by taking c.f.u counts 
after 24 h of treatment. Data represent average of three independent experiments. Error bars represent SE.  
Statistical significance was determined using students t-test to compare the result of msaABCR mutant to 
the wild type. **, P ≤0.005. 
3.5 The TCA mutants show decreased pH accompanied by increased acetate content 
in the stationary growth phase 
 In S. aureus, the TCA cycle is activated when glucose is depleted, and acetate is 
being catabolized. Deletion of TCA genes therefore obstructs the catabolism of acetate 
that is accumulated during the exponential phase of growth. As expected, we observed 
that the culture supernatants of the TCA mutants displayed lower pH as compared to the 
wild type strain (Fig. 3.5A).    
 




(A) Cells grown in 5 ml TSB to stationary state were centrifuged and supernatant was used to measure the 
pH. Error bars represent the SEM of pH of the three biological replicates. (B) Acetate was measured in the 
stationary growth phase of each strain following the manufacturer instruction.  
This result led us to examine the acetate accumulation and the results showed that 
the TCA mutants indeed have increased levels of acetate in the culture supernatant as 
compared to the wild type USA300 LAC (Fig 3.5 B).  
3.6 Decreased pH does not influence persister formation  
Since we observed decreased pH in the culture supernatants of the TCA mutants, 
we further sought to examine whether the increased persister fraction is associated with 
the acidification of the bacterial culture. To examine this, we used the TSB medium 
without glucose that would give the comparable pH in the TCA mutants. The absence of 
glucose as resulted in the similar pH with the wild type strain (Fig. 3.6 A), however, the 
persister frequency in the TCA mutant gltA and fumC was still increased and similar to 
that formed in the TSB medium (Fig. 3.6B).  
 
Figure 3.6 Measurement of pH and persister frequency in the glucose free medium 
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(A) The pH was measured in the supernatant of culture grown for 16 in the glucose free medium. (B) 
Persister fraction was measured in the stationary state cells grown in glucose free medium. Error bars 
represent the SEM of three biological replicates.  
These results suggested that the decreased pH in the culture media does not 
contribute to the increased persister fraction in the TCA mutants.  
3.7 Reduced ATP level does not confer persister cells formation  
 In S. aureus, increased fraction of persister cells is related to the reduced level of 
ATP. To examine if the increased persister cells in the TCA mutants is associated with 
reduced ATP, we measured the ATP content in the TCA mutants. Among the TCA 
mutants, gltA did not differ from the wild type strain while sucA and fumC mutants 
showed significantly reduced ATP level (Fig. 3.7). Therefore, these results suggest that 
ATP alone does not determine the persister frequency in S. aureus.  
 
Figure 3.7 Measurement of ATP 
ATP level of stationary cultures was tested with BacTiter-GloTM Microbial Cell Viability Assay kit. 
Aliquots of 50 µl bacterial suspension in TSB was carefully mixed with equal volume of BacTiter-
GloTM Reagent and incubated at room temperature for 5 minutes before the luminescence was recorded 
with emission at 560 nm. The data represent the average of three independent RFU value per CFUs of three 
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biological replicates for each individual sample. Error bars represent SE. Student’s t-test was used to 
compare the results of the wild-type to mutants.  
 
3.8 Membrane potential contributes to the persister formation in TCA mutants 
A previous study showed increased persister formation in the TCA mutants is 
caused due to decreased membrane potential (Wang et al., 2018). To examine this 
association, we measured the membrane potential in our test strains. We measured the 
membrane potential via flow cytometry using the fluorescent membrane stain DiOC2 (3) 
and compared with the USA300 LAC strain. The results showed lower membrane 
potential in the TCA mutant fumC than in the USA300 LAC strain (Fig. 3.8A), 
suggesting that the reduced membrane potential increases the persister cells formation in 
the TCA mutant. To further confirm the role of membrane potential in persister 
formation, we measured the persister fraction in the presence of the proton ionophore 
carbonyl cyanide m-chlorophenyl hydrazone (CCCP), a known inhibitor of PMF 
generation that dissipates H+ ion gradients. In the presence of CCCP, the wild type 
USA300 LAC as well as the msaABCR mutant both displayed drastic increase in persister 
fraction (Fig 3.8B). Altogether, these results suggest that the reduced membrane potential 







Figure 3.8A Measurement of membrane potential in wild type USA300 LAC and 
TCA mutant fumC.  
Stationary-phase cells washed twice with PBS were incubated with 3, 3′-
diethyloxacarbocyanine iodide (DiOC2(3)) for 30 min in room temperature. After 
incubation, the cells were subjected to flow cytometry. The data represents the ratio 








Figure 3.8B Measurement of membrane potential and persister formation in the 
presence of CCCP 
Stationary phase cells pre-incubated for 30 min with different concentrations of carbonyl cyanide m-
chlorophenyl hydrazone (CCCP) were exposed to gentamycin (20 μg/ml). At 24 h post exposure, the cells 
were harvested, washed, and plated for CFU counting. Data represent the percentage of cells survived after 
antibiotic exposure to the initial population. Data represent the average of three biological replicates. 




Table 3.2 List of strains and primers used in this study 
Strains Description/Genotype                        Source 
S. aureus USA300 LAC 
strain 
Methicillin resistant Dr. Lindsey Shaw 
msaABCR msaABCR operon deletion 
mutant in USA300 LAC 
(Sahukhal & Elasri, 2014) 
Complementation msaABCR complement in 
msaABCR mutant LAC strain 
(Sahukhal & Elasri, 2014) 
gltA SAUSA300_1641 This study 
sucA                                                        SAUSA300_1306 This study 
fumC SAUSA300_1801 This study 
Primers for qRT-PCR Sequences (5’        3’) 
gltA F AAATCGTTATGAAAGAGCAATG 
gltA R   GGATTAGGCTTAAGTGGTTCTT 
acnA F   ATAGTGTTGTAACACCTGAATTAT 
acnA R  CATATAGAGGTTGATCAGTTACAT 
icd F  ATTGCTGACATTTTCTTACAAC 
icd R AGCATCTGAAATATAGTCACCA 
sucA F   CAGATGACGTTGAAGCTACTAT 
sucA R CGACGATAACCTACTAAATCAA 
sucD F   TTGACTGAAGAAGGTATTGGTC 
sucD R  TTGACTGAAGAAGGTATTGGTC 
sdhA F  TGAAATTATGACAGCAAATGTAAC 
sdhA R   CAATATCTTCATAACGTTTCATCA 
sdhB F   TTCTATGGTTATCAATGGTCGT 
sdhB R   TAACTGGGAAAGTATTCATTGG 
fumC F  TCGAAGTAGTTTATGGTTTTGC 





CHAPTER IV- DISCUSSION 
Persister cells are transiently tolerant to the antibiotics and can resume the 
growth when the antibiotic treatment is ceased. This property of the persister cells is 
strongly associated with the recurrence of infections that signify its clinical relevance.  
In exponential phase, persister cells are produced in smaller fraction while the 
frequency increases as the culture enters into the stationary phase (B. P. Conlon et al., 
2016). Similarly, biofilms provide a favorable niche for the generation of slowly 
growing, energy depleted antibiotic tolerant persister cells. Given that the S. aureus 
chronic infections are mainly biofilm-associated, understanding the mechanisms 
underlying the formation of the persister cells is extremely important. In the last two 
decades, an increasing number of studies have focused on the mechanisms of persister 
formation. However, understanding the persister phenotype has been extremely 
challenging because of its small population size and transiency.  
In this study, we demonstrate the role of the msaABCR in energy generation in S. 
aureus. Likewise, using the mutants of TCA cycle, we show the importance of 
metabolism in persister cells formation. The slowly growing S. aureus cells are more 
tolerant to antibiotic treatment due to the target inactivation that is caused due to low-
energy state (K. Lewis, 2007, 2010). The reduced energy level is indeed associated also 
with the rare persister population that is generated in the exponential growth phase 
(Cameron et al., 2018; B. P. Conlon et al., 2016; Shan et al., 2017). These persister 
cells display low levels of expression of TCA enzymes (Zalis et al., 2019). In our 
study, we show that the deletion of the msaABCR operon in S. aureus was defective in 
persister formation, whereas there was an increased persister fraction among the TCA 
cycle mutants. These results suggested that the decreased metabolic activity corresponds 
with increased persister frequency.  
 The persister fraction is influenced with the reduced growth rate. In our study, 
although the gltA and fumC mutants exhibited reduced growth kinetics, the sucA mutant 
showed similar growth kinetics as comparable to the wild type USA300 LAC. These 
results indicate that the slow growth of the TCA mutants, gltA and fumC, did not 
determine the enhanced persister frequency in those mutants.  
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To correlate the importance of ATP with persister frequency, we measured the 
ATP level in the tested strains. Although the sucA and fumC mutants showed reduced 
ATP content as compared to the USA300 LAC, the gltA mutant showed similar level of 
ATP as with the wild type strain. Likewise, we observed a drastic increase in antibiotic 
tolerance and reduced intracellular ATP levels with other TCA mutants sucA and fumC. 
Our findings from this study indicate that the cellular energy is required for the killing 
efficiency of bactericidal antibiotics. However, multiple factors aside from ATP appear to 
cause the antibiotic tolerance. Altogether, these results suggested that the reduced ATP is 
not the only deterministic factor for persister formation. Previous studies showed that the 
persister formation in the TCA mutants are caused due to reduced membrane potential 
against ciprofloxacin (Wang et al., 2018). Consistent with this, we also found that the 
TCA mutants exhibited reduced membrane potential as compared to the wild type strains. 
It is known that the proton motive force (PMF) is required for the uptake of gentamicin 
inside the bacterial cells. The increased uptake correlates with the increased killing of the 
cells. Therefore, reduced membrane potential in the TCA mutants may have resulted in 
increased persister fraction in the presence of gentamicin.   
Previous studies have demonstrated the association between persister formation 
and membrane potential. For example, enhanced membrane potential led to decreased 
persister fraction with enhanced uptake of aminoglycoside antibiotic gentamicin 
(Allison et al., 2011; Barraud et al., 2013; Shan et al., 2015). Similarly, decreased 
membrane potential was regarded as the major cause for increased persister frequency 
in the TCA mutants of S. aureus (Wang et al., 2018). The small-colony variants of S. 
aureus display increased resistance towards aminoglycosides due to their low 
membrane potential (Kriegeskorte et al., 2014). Similarly, disruption of serA gene led to 
increased membrane potential and subsequently decreased persister frequency (Shan et 
al., 2015). A previous study demonstrated TCA intermediate metabolite fumarate 
mediated the antibiotic persistence in E. coli (Kim et al., 2016). Consistent with these 
findings, in our study too, we observed increased persister formation in the presence of 
exogenously added fumarate. However, the mechanism underlying this association is not 
clearly understood. It is, however, speculated that the accumulated fumarate may cause 
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the reduction in generation of PMF thereby increasing the persister fraction in the 
presence of gentamicin. We further need to examine this association in the presence of 
other antibiotics.  
Another study also showed increased antibiotic tolerance caused due to reduced 
ATP and membrane potential in S. aureus cells when grown in a polymicrobial culture 
(Nabb et al., 2019). Despite these clues, the complete mechanism underlying persister 
formation based upon the membrane potential is not understood. Given that the persister 
cells are of tremendous clinical significance, understanding the mechanisms of 
persister cells is important. S. aureus systemic infections that is mainly associated with 
biofilms, which are difficult to treat. So far, eradication of persisters by 
aminoglycosides has been achieved in conjunction with the metabolites mannitol and 
fructose, by an ATP-independent acyldepsipeptide antibiotic (ADEP4), by drugs in 
combination with reactive oxygen species, and by membrane disruption-mediated 
clearance in different bacterial systems (Allison et al., 2011; Briers et al., 2014; B. P. 
Conlon, 2014; Conlon et al., 2013; Cui et al., 2016). However, clinical efficacies of 
these strategies have yet to be elucidated.  
Gentamicin is a clinically relevant antibiotic to treat S. aureus infections. 
Likewise, the evidences show that the drug has been used in many infections without 
any adverse side effects (Pallagrosi, 1973; Richards et al., 1971). In addition, 
gentamicin treatment in combination with other drugs has been found to shorten the 
treatment duration (Tsuji & Rybak, 2005). These findings suggest that gentamicin is a 
potential antibiotic to treat the S. aureus infections. Therefore, we examined the 
persister cell formation in S. aureus strains in the presence of gentamicin stress. Since 
the deletion of the msaABCR operon led to a deficiency in persister formation in the 
presence of gentamicin, this study indicates that the msaABCR operon is a potential 
target to eradicate the persister cells and overcome treatment failures. Likewise, since 
the disruption of metabolic genes drastically increases persister frequency, future 
studies focusing in understanding the complete role of metabolism in the antibiotic 
tolerance in different bacterial species would be remarkable to overcome the treatment 
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